Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maho Miyazawa
Observed name:
Miyazawa Maho
Institutions:
SHOWA Medical University,
Tokyo Metropolitan Tama Medical Center
Observed institutions:
SHOWA Medical University,
Chiba-Nishi General Hospital,
Tokyo Metropolitan Tama Medical Center,
Tokyo Metropolitan University
ORCID:
0000-0001-7114-1896
Observed ORCID:
0000-0001-7114-1896
OpenAlex ID:
A5064911267
Cyclophosphamide exposure via sweat of patients receiving CHOP therapy
2022
·
Maho Miyazawa
, Rina Yamashita
, et al.
·
Journal of Oncology Pharmacy Practice
·
8
Investigating Effective Risk Communication Required for Explaining Secondary Exposure Controls for Anticancer Drugs at Home
2023
·
Maho Miyazawa
, Saori Miura
, et al.
·
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
·
3
PDF
Perceptions and information needs regarding household exposure to anticancer drugs among family members living with patients receiving outpatient chemotherapy in Japan: A qualitative descriptive study
2026
·
Maho Miyazawa
, Toshiaki Nakayama
, et al.
·
Journal of Oncology Pharmacy Practice
PDF
がん化学療法における分子標的薬の有害事象マネジメント Part 3 分子標的薬の有害事象
2017
·
Matsubayashi Mariko
, Miyazawa Maho
·
看護技術
Show more works
View as search
Works count:
4
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type